About Gracure
Gracure is a company based in Delhi (India) founded in 1992. The company has 529 employees. Gracure offers products and services including Contract Manufacturing and R&D Services.
- Headquarter Delhi, India
- Employees 529
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Social LinkedIn
- Legal Name Gracure Pharmaceuticals Limited
- Date of Incorporation 01 Jun, 1992
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹287 Cr
FY 2025 · +27% YoY
- Net Profit₹35.10 Cr
FY 2025 · 12% margin
- EBITDA₹54.74 Cr
FY 2025 · 19% margin
- Employee Count529
Associated legal entities of Gracure
Gracure operates through Gracure Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Gracure Pharmaceuticals Limited CIN U24232DL1992PLC049002 | Active | 01 Jun 1992 | New Delhi, Delhi | ₹287 Cr | 529 | 5 | View details |
Products & Services of Gracure
Gracure offers a comprehensive portfolio of products and services, including Contract Manufacturing and R&D Services.
Contract manufacturing services are offered for pharmaceuticals, including packaging options and adherence to quality standards.
R&D services are provided for drug development and analytical processes, supported by a qualified team and international approvals.
Board of directors of Gracure Pharmaceuticals Limited (Gracure)
Gracure Pharmaceuticals Limited is the primary company behind Gracure. The board of Gracure Pharmaceuticals Limited currently have 5 directors; the longest-serving is Amreshwar Sahai Bhargava, appointed in 1992. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Amreshwar Sahai Bhargava DIN 00004468 | Managing Director | 25 Nov 1992 | 33 yrs 10 mo | Gracure Pharmaceuticals Limited |
| Harshad Vaid DIN 00015098 | Director | 05 May 1995 | 31 yrs 5 mo | Gracure Pharmaceuticals Limited |
| Sudhir Bhargava DIN 00004491 | Whole-time director | 27 Nov 2001 | 24 yrs 10 mo | Gracure Pharmaceuticals Limited |
| Pradeep Kumar Rastogi DIN 00004480 | Whole-time director | 13 Mar 2002 | 24 yrs 6 mo | Gracure Pharmaceuticals Limited |
| Parag Bhargava DIN 00004475 | Whole-time director | 10 Aug 2002 | 24 yrs 2 mo | Gracure Pharmaceuticals Limited |
Financials of Gracure
Figures of Gracure Pharmaceuticals Limited, the primary company behind Gracure, for FY 2025. Revenue was ₹287 Cr (+27% year on year). Net profit was ₹35.10 Cr (12% margin). EBITDA was ₹54.74 Cr (19% margin). Revenue has grown at a compounded annual rate of +9% over three years and +17% over five years.
- ₹287 CrRevenue · FY 2025 · +27% YoY
- ₹35.10 CrNet profit · 12% margin
- ₹54.74 CrEBITDA · 19% margin
- ₹2.82 CrPaid-up capital
- 529Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Gracure Pharmaceuticals Limited are on its company page.
Detailed financial statements for Gracure
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Gracure
The website of Gracure (gracure.com) receives about 1.3K visits a month and ranks #10,580,445 among all websites worldwide, #7,943 in Biotechnology and Pharmaceuticals.
- Monthly visits1.3K
▼ 2.5% vs previous month
- Global rank#10,580,445
among all websites
- Category rank#7,943
Health · Biotechnology and Pharmaceuticals
- Bounce rate30%
- Pages per visit1.8
- Average visit45 sec
- DevicesDesktop 39% · Mobile 61%
Websites whose visitors overlap most with Gracure. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| umeshmodigroup.com | 100% | 5.3K | #2,442,534 | View details | |
| arbropharma.com | 92% | 1.6K | #9,914,782 | View details | |
| coraldrugs.com | 89% | 680.7K | #11,178,852 | View details | |
| alembicpharmaceuticals.com | 88% | 23K | #2,083,600 | View details | |
| akums.in | 83% | 25.5K | #1,037,095 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 29 similar websites and full traffic analytics for Gracure
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 29 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Gracure
10 companies that operate in the same segment as Gracure (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Gracure
Gracure was founded in 1992.
Gracure is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Gracure has 529 employees.
The primary company behind Gracure, Gracure Pharmaceuticals Limited, reported revenue of ₹287 Cr for FY 2025, up 27% year on year.
Gracure Pharmaceuticals Ltd. is recognized as one of the largest pharmaceutical companies, where end-to-end services from research to commercialization are offered through manufacturing facilities. International standards are adhered to, with approvals from bodies like EU-GMP and FDA, and operations are conducted in over 29 countries. A qualified team of scientists ensures quality assurance and process improvements, supporting developmental, manufacturing, and regulatory needs effectively.
Gracure offers Contract Manufacturing and R&D Services.
Gracure operates through Gracure Pharmaceuticals Limited.
The legal entities of Gracure currently have 5 directors, including Sudhir Bhargava, Parag Bhargava, Amreshwar Sahai Bhargava and others.